Grupo para la caracterización molecular de las neoplasias hematológicas
Washington University in St. Louis School of Medicine
San Luis, Estados UnidosPublications en collaboration avec des chercheurs de Washington University in St. Louis School of Medicine (5)
2020
-
First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Clinical Cancer Research, Vol. 26, Núm. 10, pp. 2308-2317
2018
-
Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics
Science, Vol. 359, Núm. 6372, pp. 191-199
2017
-
Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: A multicenter IMWG study
Leukemia, Vol. 31, Núm. 11, pp. 2443-2448
2016
-
A broad analysis of resistance development in the malaria parasite
Nature Communications, Vol. 7
-
International Myeloma Working Group Recommendations for the Diagnosis and Management of Myeloma-Related Renal Impairment
Journal of Clinical Oncology, Vol. 34, Núm. 13, pp. 1544-1557